share_log

Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 10 05:12
Summary by Futu AI
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.